We really hate to do this, but we must take a look at these comments made yesterday by Mark Gorder CEO of IntriCon, who in case anyone has forgotten is the leading supplier for Medtronic’s CGM system;
“Our platform technology currently addresses several high-growth medical markets, including diabetes, drug delivery, surgical navigation, and hearing health. With regards to diabetes, Medtronic is our largest single customer, represented 60% of our total revenue in 2019.
Undoubtedly, we were affected throughout the year by the timing of their ongoing global commercial product launch of the 670G and the competitive pressures domestically . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.